CorMedix Inc. (FRA:19KA)

Germany flag Germany · Delayed Price · Currency is EUR
8.90
+0.20 (2.30%)
Last updated: Dec 5, 2025, 8:10 AM CET
-4.30%
Market Cap 715.20M
Revenue (ttm) 182.65M
Net Income (ttm) 138.50M
Shares Out n/a
EPS (ttm) 1.92
PE Ratio 5.16
Forward PE 3.70
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 337
Open 8.90
Previous Close 8.70
Day's Range 8.90 - 8.90
52-Week Range 5.00 - 14.60
Beta n/a
RSI 48.21
Earnings Date Mar 25, 2026

About CorMedix

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Height... [Read more]

Industry Pharmaceutical Preparations
Founded 2006
Employees 65
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 19KA
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.